title: Emerging concepts in haematopoietic cell transplantation.
abstract: Haematopoietic cell transplantation (HCT) is the most widely used form of cellular therapy. It is the only known cure for some haematological malignancies and has recently been used in additional clinical settings, such as allograft tolerance induction and treatment of autoimmune diseases. Recent advances have enabled HCT in a wider range of patients with improved outcomes. This Review summarizes the latest developments in this therapy, focusing on issues that will affect future advancement.
authors.affiliation: Columbia Center for Translational Immunology, Columbia University Medical Center, 650 West 168th Street, BB 15-02, New York, New York                 10032, USA.
authors.forename: Hao Wei
authors.initials: HW
authors.lastname: Li
authors.forename: Megan
authors.initials: M
authors.lastname: Sykes
mesh_terms: D000818:Animals; D001327:Autoimmune Diseases / Q000628:therapy; D005312:Fetal Blood / Q000276:immunology; D006086:Graft vs Host Disease / Q000628:therapy; D006680:HLA Antigens / Q000276:immunology; D019337:Hematologic Neoplasms / Q000628:therapy; D018380:Hematopoietic Stem Cell Transplantation / Q000379:methods* / Q000592:standards; D006801:Humans; D019172:Transplantation Conditioning / Q000379:methods
chemical_list: D006680:HLA Antigens